Cargando…

Disinfectants In Interventional Practices

PURPOSE OF REVIEW: This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review’s goal is to add to the body of literature available on this topic and give interventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranke, Mayank, Moheimani, Roya, Phuphanich, Melissa, Kaye, Alan D., Ngo, Anh L., Viswanath, Omar, Herman, Jared
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946573/
https://www.ncbi.nlm.nih.gov/pubmed/33693989
http://dx.doi.org/10.1007/s11916-021-00938-3
_version_ 1783663081009709056
author Aranke, Mayank
Moheimani, Roya
Phuphanich, Melissa
Kaye, Alan D.
Ngo, Anh L.
Viswanath, Omar
Herman, Jared
author_facet Aranke, Mayank
Moheimani, Roya
Phuphanich, Melissa
Kaye, Alan D.
Ngo, Anh L.
Viswanath, Omar
Herman, Jared
author_sort Aranke, Mayank
collection PubMed
description PURPOSE OF REVIEW: This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review’s goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures. RECENT FINDINGS: In the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. SUMMARY: The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting.
format Online
Article
Text
id pubmed-7946573
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79465732021-03-11 Disinfectants In Interventional Practices Aranke, Mayank Moheimani, Roya Phuphanich, Melissa Kaye, Alan D. Ngo, Anh L. Viswanath, Omar Herman, Jared Curr Pain Headache Rep Chronic Pain Medicine (O Viswanath, Section Editor) PURPOSE OF REVIEW: This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review’s goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures. RECENT FINDINGS: In the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. SUMMARY: The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting. Springer US 2021-03-11 2021 /pmc/articles/PMC7946573/ /pubmed/33693989 http://dx.doi.org/10.1007/s11916-021-00938-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Chronic Pain Medicine (O Viswanath, Section Editor)
Aranke, Mayank
Moheimani, Roya
Phuphanich, Melissa
Kaye, Alan D.
Ngo, Anh L.
Viswanath, Omar
Herman, Jared
Disinfectants In Interventional Practices
title Disinfectants In Interventional Practices
title_full Disinfectants In Interventional Practices
title_fullStr Disinfectants In Interventional Practices
title_full_unstemmed Disinfectants In Interventional Practices
title_short Disinfectants In Interventional Practices
title_sort disinfectants in interventional practices
topic Chronic Pain Medicine (O Viswanath, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946573/
https://www.ncbi.nlm.nih.gov/pubmed/33693989
http://dx.doi.org/10.1007/s11916-021-00938-3
work_keys_str_mv AT arankemayank disinfectantsininterventionalpractices
AT moheimaniroya disinfectantsininterventionalpractices
AT phuphanichmelissa disinfectantsininterventionalpractices
AT kayealand disinfectantsininterventionalpractices
AT ngoanhl disinfectantsininterventionalpractices
AT viswanathomar disinfectantsininterventionalpractices
AT hermanjared disinfectantsininterventionalpractices